Literature DB >> 26530915

Analyses of Tumor Burden In Vivo and Metastasis Ex Vivo Using Luciferase-Expressing Cancer Cells in an Orthotopic Mouse Model of Neuroblastoma.

Frances L Byrne1, Joshua A McCarroll2,3, Maria Kavallaris4,5.   

Abstract

Cancer xenograft mouse models are useful for examining and understanding tumor growth and cancer progression in vivo. With the development of bioluminescent imaging, these parameters can now be monitored noninvasively with relative ease. Herein we describe imaging of luciferase-expressing cancer cells to quantitatively measure tumor burden in vivo and metastases ex vivo. Specifically, we detail the methodology to examine the effect of shRNA-mediated knockdown of a target gene on the growth and spread of neuroblastoma tumors in immune-deficient mice.

Entities:  

Keywords:  Luciferase; Metastasis; Neuroblastoma; Orthotopic; Short hairpin RNA

Mesh:

Substances:

Year:  2016        PMID: 26530915     DOI: 10.1007/978-1-4939-3148-4_5

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  5 in total

1.  Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment.

Authors:  Laura E Stevens; Anna Arnal-Estapé; Don X Nguyen
Journal:  J Vis Exp       Date:  2018-06-28       Impact factor: 1.355

2.  Accelerating development of high-risk neuroblastoma patient-derived xenograft models for preclinical testing and personalised therapy.

Authors:  Alvin Kamili; Andrew J Gifford; Nancy Li; Chelsea Mayoh; Shu-Oi Chow; Timothy W Failes; Georgina L Eden; Roxanne Cadiz; Jinhan Xie; Robyn E Lukeis; Murray D Norris; Michelle Haber; Geoffrey B McCowage; Greg M Arndt; Toby N Trahair; Jamie I Fletcher
Journal:  Br J Cancer       Date:  2020-01-10       Impact factor: 7.640

3.  Nanocarrier-Based Delivery of SN22 as a Tocopheryl Oxamate Prodrug Achieves Rapid Tumor Regression and Extends Survival in High-Risk Neuroblastoma Models.

Authors:  Ivan S Alferiev; David T Guerrero; Danielle Soberman; Peng Guan; Ferro Nguyen; Venkatadri Kolla; Ilia Fishbein; Blake B Pressly; Garrett M Brodeur; Michael Chorny
Journal:  Int J Mol Sci       Date:  2022-02-03       Impact factor: 5.923

4.  Poloxamer-linked prodrug of a topoisomerase I inhibitor SN22 shows efficacy in models of high-risk neuroblastoma with primary and acquired chemoresistance.

Authors:  Ivan S Alferiev; David T Guerrero; Peng Guan; Ferro Nguyen; Venkatadri Kolla; Danielle Soberman; Benjamin B Pressly; Ilia Fishbein; Garrett M Brodeur; Michael Chorny
Journal:  FASEB J       Date:  2022-03       Impact factor: 5.834

5.  Generation of Luciferase-expressing Tumor Cell Lines.

Authors:  Todd V Brennan; Liwen Lin; Xiaopei Huang; Yiping Yang
Journal:  Bio Protoc       Date:  2018-04-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.